Top compounds associated with response to SSPO


Feature Type Standardized
Nominal ANOVA
mRNA nintedanib CTRPv2 pan-cancer AAC 0.13 0.0006
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA RDEA119 GDSC1000 pan-cancer AAC -0.1 0.0008
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0008
mRNA chlorambucil CTRPv2 pan-cancer AAC 0.1 0.0009
mRNA ZSTK474 CTRPv2 pan-cancer AAC 0.12 0.0009
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.11 0.001
mRNA SMER-3 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA KU-60019 CTRPv2 pan-cancer AAC 0.11 0.001
Download CSV